Get started
Author

Federica Rizzo

Observed names: F. Rizzo, Rizzo, Federica
ORCID: 0000-0002-7677-0330
Observed ORCID: 0000-0002-7677-0330
OpenAlex ID: A5082719787
Neural Stem Cell Transplantation for Neurodegenerative Diseases
2020 · Roberta De Gioia, Fabio Biella, et al. · International Journal of Molecular Sciences · 246
PDF
Genetic Correction of Human Induced Pluripotent Stem Cells from Patients with Spinal Muscular Atrophy
2012 · Stefania Corti, Monica Nizzardo, et al. · Science Translational Medicine · 207
Direct reprogramming of human astrocytes into neural stem cells and neurons
2012 · Stefania Corti, Monica Nizzardo, et al. · Experimental Cell Research · 159
PDF
MFN2-related neuropathies: Clinical features, molecular pathogenesis and therapeutic perspectives
2015 · Giulia Stuppia, Federica Rizzo, et al. · Journal of the Neurological Sciences · 142
Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model
2013 · Monica Nizzardo, Chiara Simone, et al. · Human Molecular Genetics · 112
PDF
Mitochondrial Fusion Proteins and Human Diseases
2013 · Michela Ranieri, Simona Brajkovic, et al. · Neurology Research International · 110
PDF
Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis
2013 · Federica Rizzo, Giulietta Riboldi, et al. · Cellular and Molecular Life Sciences · 93
PDF
Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies
2011 · Sabrina Salani, Chiara Donadoni, et al. · Journal of Cellular and Molecular Medicine · 70
PDF
Selective mitochondrial depletion, apoptosis resistance, and increased mitophagy in human Charcot-Marie-Tooth 2A motor neurons
2016 · Federica Rizzo, Dario Ronchi, et al. · Human Molecular Genetics · 62
Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model
2015 · Monica Nizzardo, Chiara Simone, et al. · Science Advances · 58
Effect of Combined Systemic and Local Morpholino Treatment on the Spinal Muscular Atrophy Δ7 Mouse Model Phenotype
2014 · Monica Nizzardo, Chiara Simone, et al. · Clinical Therapeutics · 53
Synaptotagmin 13 is neuroprotective across motor neuron diseases
2020 · M. Nizzardo, M. Taiana, et al. · Acta Neuropathologica · 50
PDF
Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches
2015 · Monica Nizzardo, Chiara Simone, et al. · Scientific Reports · 44
PDF
Key role of SMN/SYNCRIP and RNA-Motif 7 in spinal muscular atrophy: RNA-Seq and motif analysis of human motor neurons
2018 · Federica Rizzo, Monica Nizzardo, et al. · Brain · 43
PDF
iPSC-Derived Neural Stem Cells Act via Kinase Inhibition to Exert Neuroprotective Effects in Spinal Muscular Atrophy with Respiratory Distress Type 1
2014 · Chiara Simone, Monica Nizzardo, et al. · Stem Cell Reports · 38
PDF
Charcot-Marie-tooth disease type 2A: An update on pathogenesis and therapeutic perspectives
2024 · Claudia Alberti, Federica Rizzo, et al. · Neurobiology of Disease · 36
Stathmins and Motor Neuron Diseases: Pathophysiology and Therapeutic Targets
2022 · Delia Gagliardi, Elisa Pagliari, et al. · Biomedicines · 33
PDF
Morpholino-mediated SOD1 reduction ameliorates an amyotrophic lateral sclerosis disease phenotype
2016 · M. Nizzardo, C. Simone, et al. · Scientific Reports · 33
PDF
Clinical and genetic features of a cohort of patients with MFN2-related neuropathy
2022 · Elena Abati, Arianna Manini, et al. · Scientific Reports · 31
PDF
Genome-wide RNA-seq of iPSC-derived motor neurons indicates selective cytoskeletal perturbation in Brown–Vialetto disease that is partially rescued by riboflavin
2017 · Federica Rizzo, Agnese Ramirez, et al. · Scientific Reports · 29
PDF
Disease Modeling and Therapeutic Strategies in CMT2A: State of the Art
2019 · Kordelia Barbullushi, Elena Abati, et al. · Molecular Neurobiology · 24
Combined RNA interference and gene replacement therapy targeting MFN2 as proof of principle for the treatment of Charcot–Marie–Tooth type 2A
2023 · Federica Rizzo, Silvia Bono, et al. · Cellular and Molecular Life Sciences · 21
PDF
Downregulation of glutamic acid decarboxylase in Drosophila TDP-43-null brains provokes paralysis by affecting the organization of the neuromuscular synapses
2018 · Giulia Romano, Nikola Holodkov, et al. · Scientific Reports · 21
PDF
Research advances in gene therapy approaches for the treatment of amyotrophic lateral sclerosis
2011 · Monica Nizzardo, Chiara Simone, et al. · Cellular and Molecular Life Sciences · 21
Targeting STMN2 for neuroprotection and neuromuscular recovery in Spinal Muscular Atrophy: evidence from in vitro and in vivo SMA models
2024 · Elisa Pagliari, Michela Taiana, et al. · Cellular and Molecular Life Sciences · 10
PDF
Works count: 46
Citation count: 1,776
H-index: 21
I10-index: 26
Year
Topic
Type